Publisher
Springer Science and Business Media LLC
Reference82 articles.
1. Hagemeier, K., Bruck, W. & Kuhlmann, T. Multiple sclerosis - remyelination failure as a cause of disease progression. Histol Histopathol 27, 277–287 (2012).
2. Patten, S. B., Beck, C. A., Williams, J. V., Barbui, C. & Metz, L. M. Major depression in multiple sclerosis: a population-based perspective. Neurology 61, 1524–1527 (2003).
3. Mohr, D. C., Hart, S. L., Fonareva, I. & Tasch, E. S. Treatment of depression for patients with multiple sclerosis in neurology clinics. Multiple sclerosis (Houndmills, Basingstoke, England) 12, 204–208 (2006).
4. Vattakatuchery, J. J., Rickards, H. & Cavanna, A. E. Pathogenic mechanisms of depression in multiple sclerosis. The Journal of neuropsychiatry and clinical neurosciences 23, 261–276, doi: 10.1176/jnp.23.3.jnp261 (2011).
5. Abdel-Salam, O. M., Safaa, M. Y. M. & Amany, A. S. The effect of different antidepressant drugs on oxidative stress after lipopolysaccharide administration in mice. EXCLI Journal 10, 290–302 (2011).
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献